Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in the United States with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Status: Unknown status Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20091
20121
20131
20151
20171
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology1
Center for International Blood and Marrow Transplant Research1
Colorado Blood Cancer Institute1
Diane George1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
Herbert Irving Comprehensive Cancer Center1
Jonsson Comprehensive Cancer Center1
Kartos Therapeutics, Inc.1
M.D. Anderson Cancer Center1
New York Medical College1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive11
Leukemia5
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Leukemia, Myeloid, Acute4
Lymphoma3
Myelodysplastic Syndromes3
Burkitt Lymphoma2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myeloid, Chronic-Phase2
Leukemia, Myelomonocytic, Juvenile2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.